Kailera Therapeutics, Inc.

NASDAQ:KLRA

Biotechnology

Healthcare
$11.79 +2.66%

+$0.51 today

Market cap
$1.53B
Beta
0.00
52W Low $18.50High $28.23

Volume 0.42M

Average 0.80M

KLRA Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Kailera Therapeutics, Inc.NASDAQ: KLRA

Weighted Avg Shares (Diluted) · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares (diluted) of 102.23M shares in Q2 FY2026

Q2 FY2026 weighted avg shares (diluted) was 102.23M shares.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
102.23M-13.3% QoQ
Last fiscal yearDec 2025
117.95M— YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
117.95M USD
Year-over-year change
—

Weighted Avg Shares (Diluted) vs competitors

How KLRA compares with its peers on the latest reported figures

  • KLRA's FY2025 weighted avg shares (diluted) of 117.95M shares is the 2nd highest of the 10 companies compared; the peer median is 56.46M shares.
KLRA Competitors Peer median
Weighted Avg Shares (Diluted) for KLRA and competitors
Company Period LTM YoY 3-year CAGR
NAMSNewAmsterdam Pharma Company N.V.LTM Jun 2026119.47M +13.7%+82.0%
KLRAKailera Therapeutics, Inc.FY2025117.95M ——
VKTXViking Therapeutics, Inc.LTM Jun 2026114.45M +2.5%+13.6%
ALTAltimmune, Inc.LTM Mar 202698.99M +37.1%+23.4%
GUTSFractyl Health, Inc. Common StockLTM Mar 202666.33M +37.1%+16.8%
BMEABiomea Fusion, Inc.LTM Mar 202656.46M +55.6%+21.3%
MBXMBX Biosciences, Inc. Common StockLTM Sep 202644.83M +33.4%+4.6%
ORMPOramed Pharmaceuticals Inc.LTM Mar 202642.44M +3.8%+2.8%
BIOABioAge Labs, Inc.LTM Mar 202637.57M +7.3%+1.7%
VTVTvTv Therapeutics Inc.LTM Mar 20267.87M +30.1%+63.7%
Peer median (excluding KLRA) 56.46M+30.1%+16.8%

Competitors are the stored peer set for KLRA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Kailera Therapeutics, Inc.

NASDAQ:KLRA

Intrinsic Alpha fair value

Locked

Current Price

$11.79

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.